Emerald Bioscience, Inc. (48) | Uncategorized (13)

Recent Contracts

Amendment No. 2 to (Filed With SEC on July 21, 2022)
Amendment No. 1 to Plan of Arrangement (Filed With SEC on June 17, 2022)
Skye Support Agreement (Filed With SEC on May 23, 2022)
EHT Support Agreement (Filed With SEC on May 23, 2022)
Notice of Option Amendment (Filed With SEC on March 28, 2022)
Exclusive Sponsored Research Agreement, dated October 12, 2021, by and between the Company and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on October 15, 2021)
Form of Lock-up Agreement (Filed With SEC on September 28, 2021)
Collaborative Research Agreement, dated April 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on August 6, 2021)
Form of Letter Agreement (Filed With SEC on July 22, 2021)
Collaborative Research Agreement, dated January 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on March 2, 2021)
Start-Up Agreement, dated as of August 23, 2019, by and between the Company and Novotech (Filed With SEC on August 27, 2019)
Secured Promissory Note, dated December 28, 2017, by Nemus Bioscience, Inc., to Emerald Health Sciences Inc (Filed With SEC on January 3, 2018)
Security Agreement, dated December 28, 2017, by and among Nemus Bioscience, Inc., and Emerald Health Sciences Inc (Filed With SEC on January 3, 2018)